Published in Transpl Infect Dis on October 26, 2010
Deletion of Fibrinogen-like Protein 2 (FGL-2), a Novel CD4+ CD25+ Treg Effector Molecule, Leads to Improved Control of Echinococcus multilocularis Infection in Mice. PLoS Negl Trop Dis (2015) 0.83
The first locally acquired human infection of Echinococcus multilocularis in The Netherlands. J Clin Microbiol (2012) 0.81
30-yr course and favorable outcome of alveolar echinococcosis despite multiple metastatic organ involvement in a non-immune suppressed patient. Ann Clin Microbiol Antimicrob (2013) 0.80
Homo- and heterodimeric interactions between the gene products of PKD1 and PKD2. Proc Natl Acad Sci U S A (1997) 3.06
Quantitative 2D and 3D phase contrast MRI: optimized analysis of blood flow and vessel wall parameters. Magn Reson Med (2008) 2.71
Tumor necrosis factor-alpha, interleukin-1 beta, and interleukin-6 expression in inflammatory bowel disease. Dig Dis Sci (1992) 2.47
The polycystic kidney disease 1 gene product modulates Wnt signaling. J Biol Chem (1999) 2.37
Is the frequency of self-monitoring of blood glucose related to long-term metabolic control? Multicenter analysis including 24,500 patients from 191 centers in Germany and Austria. Exp Clin Endocrinol Diabetes (2006) 2.28
CD62/P-selectin recognition of myeloid and tumor cell sulfatides. Cell (1991) 2.16
Specific association of the gene product of PKD2 with the TRPC1 channel. Proc Natl Acad Sci U S A (1999) 2.09
Dobutamine-stress magnetic resonance microimaging in mice : acute changes of cardiac geometry and function in normal and failing murine hearts. Circ Res (2001) 2.08
Interaction with podocin facilitates nephrin signaling. J Biol Chem (2001) 2.08
Comprehensive genetic characterization of CLL: a study on 506 cases analysed with chromosome banding analysis, interphase FISH, IgV(H) status and immunophenotyping. Leukemia (2007) 1.97
The role of adjuvant chemotherapy following cystectomy for invasive bladder cancer: a prospective comparative trial. J Urol (1991) 1.81
Upregulation of RGS7 may contribute to tumor necrosis factor-induced changes in central nervous function. Nat Med (1999) 1.80
Karyotype is an independent prognostic parameter in therapy-related acute myeloid leukemia (t-AML): an analysis of 93 patients with t-AML in comparison to 1091 patients with de novo AML. Leukemia (2004) 1.77
The detection of TP53 mutations in chronic lymphocytic leukemia independently predicts rapid disease progression and is highly correlated with a complex aberrant karyotype. Leukemia (2008) 1.76
Nephrocystin interacts with Pyk2, p130(Cas), and tensin and triggers phosphorylation of Pyk2. Proc Natl Acad Sci U S A (2001) 1.73
Mutations of the TP53 gene in acute myeloid leukemia are strongly associated with a complex aberrant karyotype. Leukemia (2008) 1.70
Polycystic kidney disease: cell division without a c(l)ue? Kidney Int (2006) 1.67
Mutation analysis for RUNX1, MLL-PTD, FLT3-ITD, NPM1 and NRAS in 269 patients with MDS or secondary AML. Leukemia (2010) 1.65
Reliability of aortic MRI at 3 Tesla in patients with acute cryptogenic stroke. J Neurol Neurosurg Psychiatry (2007) 1.64
Primary mouse hepatocytes for systems biology approaches: a standardized in vitro system for modelling of signal transduction pathways. Syst Biol (Stevenage) (2006) 1.63
The T cell activation antigen CD27 is a member of the nerve growth factor/tumor necrosis factor receptor gene family. J Immunol (1991) 1.60
SETBP1 mutations occur in 9% of MDS/MPN and in 4% of MPN cases and are strongly associated with atypical CML, monosomy 7, isochromosome i(17)(q10), ASXL1 and CBL mutations. Leukemia (2013) 1.57
The polycystic kidney disease 1 gene product mediates protein kinase C alpha-dependent and c-Jun N-terminal kinase-dependent activation of the transcription factor AP-1. J Biol Chem (1998) 1.57
Standardization of flow cytometry in myelodysplastic syndromes: a report from an international consortium and the European LeukemiaNet Working Group. Leukemia (2012) 1.57
Neuropsychiatric side effects after the use of mefloquine. Am J Trop Med Hyg (1991) 1.53
Sleep disruption alters nocturnal ACTH and cortisol secretory patterns. Biol Psychiatry (1991) 1.51
Molecular profiling of chronic myelomonocytic leukemia reveals diverse mutations in >80% of patients with TET2 and EZH2 being of high prognostic relevance. Leukemia (2011) 1.45
ASXL1 exon 12 mutations are frequent in AML with intermediate risk karyotype and are independently associated with an adverse outcome. Leukemia (2012) 1.42
Wnt signaling and transcriptional control of Siamois in Xenopus embryos. Proc Natl Acad Sci U S A (1998) 1.41
Flow cytometric identification of acute myeloid leukemia with limited differentiation and NPM1 type A mutation: a new biologically defined entity. Leukemia (2009) 1.40
Report on two novel nucleotide exchanges in the JAK2 pseudokinase domain: D620E and E627E. Leukemia (2006) 1.40
Landscape of TET2 mutations in acute myeloid leukemia. Leukemia (2011) 1.35
New insights into MLL gene rearranged acute leukemias using gene expression profiling: shared pathways, lineage commitment, and partner genes. Leukemia (2005) 1.32
A deep-sequencing study of chronic myeloid leukemia patients in blast crisis (BC-CML) detects mutations in 76.9% of cases. Leukemia (2011) 1.31
14-3-3 interacts with regulator of G protein signaling proteins and modulates their activity. J Biol Chem (2000) 1.27
AML with translocation t(8;16)(p11;p13) demonstrates unique cytomorphological, cytogenetic, molecular and prognostic features. Leukemia (2009) 1.27
The selfish brain: competition for energy resources. Prog Brain Res (2006) 1.26
Management of acute myeloid leukemia in elderly patients. J Clin Oncol (1999) 1.25
Detection of an MPLW515 mutation in a case with features of both essential thrombocythemia and refractory anemia with ringed sideroblasts and thrombocytosis. Leukemia (2007) 1.22
Transforming growth factor beta1 is a target for the von Hippel-Lindau tumor suppressor and a critical growth factor for clear cell renal carcinoma. Cancer Res (1999) 1.21
In vivo assessment and visualization of intracranial arterial hemodynamics with flow-sensitized 4D MR imaging at 3T. AJNR Am J Neuroradiol (2007) 1.20
Cellular activation triggered by the autosomal dominant polycystic kidney disease gene product PKD2. Mol Cell Biol (1999) 1.20
Prognostic impact of FLT3-ITD load in NPM1 mutated acute myeloid leukemia. Leukemia (2011) 1.18
Dependence of age-specific incidence of acute myeloid leukemia on karyotype. Blood (2001) 1.17
3D blood flow characteristics in the carotid artery bifurcation assessed by flow-sensitive 4D MRI at 3T. Magn Reson Med (2009) 1.16
Prognostic impact of RT-PCR-based quantification of WT1 gene expression during MRD monitoring of acute myeloid leukemia. Leukemia (2005) 1.12
Obese men respond to cognitive but not to catabolic brain insulin signaling. Int J Obes (Lond) (2007) 1.11
Genomic gains and losses influence expression levels of genes located within the affected regions: a study on acute myeloid leukemias with trisomy 8, 11, or 13, monosomy 7, or deletion 5q. Leukemia (2005) 1.09
Interaction between RGS7 and polycystin. Proc Natl Acad Sci U S A (1999) 1.09
Low cerebrospinal fluid insulin levels in obese humans. Diabetologia (2006) 1.08
High dose ara-C in the treatment of newly diagnosed acute promyelocytic leukemia: long-term results of the German AMLCG. Leukemia (2009) 1.07
Serum leptin is associated with serum uric acid concentrations in humans. Metabolism (1999) 1.05
Cell surface characterization of T lymphocytes and allergen-specific T cell clones: correlation of CD26 expression with T(H1) subsets. J Allergy Clin Immunol (1997) 1.03
Prognostic impact and landscape of NOTCH1 mutations in chronic lymphocytic leukemia (CLL): a study on 852 patients. Leukemia (2013) 1.03
Glucose metabolism rather than insulin is a main determinant of leptin secretion in humans. J Clin Endocrinol Metab (2000) 1.03
Acute erythroid leukemia (AEL) can be separated into distinct prognostic subsets based on cytogenetic and molecular genetic characteristics. Leukemia (2013) 1.03
Evidence that glucocorticosteroids block expression of the human interleukin-6 gene by accessory cells. Transplantation (1990) 1.02
Landmark analysis of DNMT3A mutations in hematological malignancies. Leukemia (2013) 1.02
Cadmium and lead in the smoke of a filter cigarette. Sci Total Environ (1993) 1.02
Immunophenotyping of acute leukemia and lymphoproliferative disorders: a consensus proposal of the European LeukemiaNet Work Package 10. Leukemia (2011) 1.01
Frequency and causes of refractoriness in multiply transfused patients. Ann Hematol (1997) 1.01
Pediatric acute lymphoblastic leukemia (ALL) gene expression signatures classify an independent cohort of adult ALL patients. Leukemia (2004) 1.01
STAT3 mutations are highly specific for large granular lymphocytic leukemia. Leukemia (2012) 1.00
AML with CBFB-MYH11 rearrangement demonstrate RAS pathway alterations in 92% of all cases including a high frequency of NF1 deletions. Leukemia (2010) 1.00
GATA2 mutations are frequent in intermediate-risk karyotype AML with biallelic CEBPA mutations and are associated with favorable prognosis. Leukemia (2012) 1.00
The cytoplasmic C-terminal fragment of polycystin-1 regulates a Ca2+-permeable cation channel. J Biol Chem (2000) 1.00
Aldehydic lipid peroxidation products derived from linoleic acid. Biochim Biophys Acta (2001) 0.98
3D MR flow analysis in realistic rapid-prototyping model systems of the thoracic aorta: comparison with in vivo data and computational fluid dynamics in identical vessel geometries. Magn Reson Med (2008) 0.98
Lymphocyte subsets in peripheral blood and smoking habits. Lung (1997) 0.98
[S3-guideline on ambulant acquired pneumonia and deep airway infections]. Pneumologie (2005) 0.97
JAK2 seems to be a typical cooperating mutation in therapy-related t(8;21)/ AML1-ETO-positive AML. Leukemia (2006) 0.97
A sialyl-Le(x)-negative melanoma cell line binds to E-selectin but not to P-selectin. Cancer Res (1994) 0.96
Nocturnal adrenocorticotropin and cortisol secretion depends on sleep duration and decreases in association with spontaneous awakening in the morning. J Clin Endocrinol Metab (1992) 0.96
Cyclosporin metabolites and central-nervous-system toxicity. Lancet (1988) 0.96
Characterization of NPM1-mutated AML with a history of myelodysplastic syndromes or myeloproliferative neoplasms. Leukemia (2011) 0.95
Intranasal insulin to improve developmental delay in children with 22q13 deletion syndrome: an exploratory clinical trial. J Med Genet (2008) 0.94
The C/EBP homologous protein CHOP (GADD153) is an inhibitor of Wnt/TCF signals. Oncogene (2006) 0.94
Night-time plasma cortisol secretion is associated with specific sleep stages. Biol Psychiatry (1986) 0.93
High incidence of RAS signalling pathway mutations in MLL-rearranged acute myeloid leukemia. Leukemia (2013) 0.93
Adaptation of cognitive function to hypoglycemia in healthy men. Diabetes Care (2000) 0.93
Relevant imaging findings of cerebral aspergillosis on MRI: a retrospective case-based study in immunocompromised patients. Eur J Neurol (2007) 0.93
Pharmacokinetics of cisplatin and relation to nephrotoxicity in paediatric patients. Eur J Clin Pharmacol (2001) 0.92
Serum adiponectin concentrations during a 72-hour fast in over- and normal-weight humans. Int J Obes (Lond) (2005) 0.91
[Diagnosis of and therapy for hepatocellular carcinoma]. Z Gastroenterol (2013) 0.91
Proliferative activity of leukaemic blasts and cytosine arabinoside pharmacodynamics are associated with cytogenetically defined prognostic subgroups in acute myeloid leukaemia. Br J Haematol (2001) 0.91
A comparative study of polymerization lamps to determine the degree of cure of composites using infrared spectroscopy. Eur J Orthod (2004) 0.91
Supraphysiological hyperinsulinemia acutely increases hypothalamic-pituitary-adrenal secretory activity in humans. J Clin Endocrinol Metab (1999) 0.89
The melanocortin melanocyte-stimulating hormone/adrenocorticotropin(4-10) decreases body fat in humans. J Clin Endocrinol Metab (2001) 0.89
Mural inflammatory hyperenhancement in MRI of giant cell (temporal) arteritis resolves under corticosteroid treatment. Rheumatology (Oxford) (2008) 0.88
A rare but specific subset of adult AML patients can be defined by the cytogenetically cryptic NUP98-NSD1 fusion gene. Leukemia (2012) 0.88
Quantitative trait loci modulate renal cystic disease severity in the mouse bpk model. J Am Soc Nephrol (2000) 0.88
Bacteremia caused by Stomatococcus mucilaginosus: report of seven cases and review of the literature. Infection (1992) 0.88